Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Targeted therapy with antineoplastons A10 and AS2-1 of high-grade, recurrent, and progressive brainstem glioma.
Burzynski SR, Janicki TJ, Weaver RA, Burzynski B. Burzynski SR, et al. Among authors: janicki tj. Integr Cancer Ther. 2006 Mar;5(1):40-7. doi: 10.1177/1534735405285380. Integr Cancer Ther. 2006. PMID: 16484713 Free article. Clinical Trial.
Complete response and long-term survival (>20 years) of a child with tectal glioma: a case report.
Burzynski SR, Burzynski GS, Janicki TJ, Marszalek A. Burzynski SR, et al. Among authors: janicki tj. Pediatr Neurosurg. 2015;50(2):99-103. doi: 10.1159/000369907. Epub 2015 Apr 22. Pediatr Neurosurg. 2015. PMID: 25926271 Free article.
The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma.
Burzynski SR, Janicki TJ, Burzynski GS, Marszalek A. Burzynski SR, et al. Among authors: janicki tj. Childs Nerv Syst. 2014 Dec;30(12):2051-61. doi: 10.1007/s00381-014-2401-z. Epub 2014 Apr 10. Childs Nerv Syst. 2014. PMID: 24718705 Free PMC article. Clinical Trial.
Long-term survival (>13 years) in a child with recurrent diffuse pontine gliosarcoma: a case report.
Burzynski SR, Janicki TJ, Burzynski GS, Marszalek A. Burzynski SR, et al. Among authors: janicki tj. J Pediatr Hematol Oncol. 2014 Oct;36(7):e433-9. doi: 10.1097/MPH.0000000000000020. J Pediatr Hematol Oncol. 2014. PMID: 24136026 Free PMC article.
Phase II study of antineoplaston A10 and AS2-1 in patients with recurrent diffuse intrinsic brain stem glioma: a preliminary report.
Burzynski SR, Lewy RI, Weaver RA, Axler ML, Janicki TJ, Jurida GF, Paszkowiak JK, Szymkowski BG, Khan MI, Bestak M. Burzynski SR, et al. Among authors: janicki tj. Drugs R D. 2003;4(2):91-101. doi: 10.2165/00126839-200304020-00002. Drugs R D. 2003. PMID: 12718563 Clinical Trial.
Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma : a preliminary report.
Burzynski SR, Weaver RA, Lewy RI, Janicki TJ, Jurida GF, Szymkowski BG, Khan MI, Bestak M. Burzynski SR, et al. Among authors: janicki tj. Drugs R D. 2004;5(6):315-26. doi: 10.2165/00126839-200405060-00002. Drugs R D. 2004. PMID: 15563234 Clinical Trial.
Long-term survival and complete response of a patient with recurrent diffuse intrinsic brain stem glioblastoma multiforme.
Burzynski SR, Lewy RI, Weaver R, Janicki T, Jurida G, Khan M, Larisma CB, Paszkowiak J, Szymkowski B. Burzynski SR, et al. Integr Cancer Ther. 2004 Sep;3(3):257-61. doi: 10.1177/1534735404267748. Integr Cancer Ther. 2004. PMID: 15312271
Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with antineoplastons A10 and AS2-1.
Burzynski SR, Weaver RA, Janicki T, Szymkowski B, Jurida G, Khan M, Dolgopolov V. Burzynski SR, et al. Integr Cancer Ther. 2005 Jun;4(2):168-77. doi: 10.1177/1534735405276835. Integr Cancer Ther. 2005. PMID: 15911929 Clinical Trial.
Feedback